Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006. - Wikidata - awgldk - TriplyDB

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

http://www.wikidata.org/entity/Q37689787

about

Effects of Anterior Capsulotomy on Decision Making in Patients with Refractory Obsessive-Compulsive Disorder.

P2860

Q44677101-6AC81F7E-7924-4D18-9F47-B65FA29BFC8E

P2860

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

http://www.wikidata.org/entity/Q37689787

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

@en

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

@nl

type

label

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

@en

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

@nl

prefLabel

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

@en

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

@nl

P1433

Q37689787-F527F6A1-94BC-4920-B47B-140607844D83

P1476

Q37689787-2FD28E47-5F97-4BEC-A13F-8FEDFF3982A1

P2093

Q37689787-7854C718-92AA-4499-A915-AC444758C31F

Q37689787-C2233C11-A52D-4E65-B03F-ABD5468A3DA4

P2860

Q37689787-00A057E6-E292-4D3D-90FB-6D0AA01BB2F8

Q37689787-02A737A7-5A47-479E-859F-202A3C8D984C

Q37689787-02B38413-3B3A-4807-A56C-0152653D5F33

Q37689787-0483530F-3E99-45E2-ACFB-09C8A40D8633

Q37689787-09C20777-8989-4B16-9A3A-EBA350493523

Q37689787-0B5F10CE-CE05-466B-B94B-1E1E18C6076A

Q37689787-0E481D04-ECE6-4FEC-B6AE-FAA39A687328

Q37689787-1126F2AC-8A2C-4424-823F-994D9769A36D

Q37689787-12286465-C7FF-4656-9DD0-19436A5EF7B5

Q37689787-16AF15F3-B169-4E5C-B791-4F5D0732F84C

P304

Q37689787-0240E53E-66D1-47BF-9B07-B0B509F11FE6

P31

Q37689787-41FA6DA0-8B3B-4D7B-B382-5DFFB9A7124E

P356

Q37689787-7C8C8D01-FA69-47AD-84E9-974CB16B04DD

P407

Q37689787-01A37D83-EEA8-4384-BDDA-74B529852DD4

P433

Q37689787-8CDB3C90-81B4-48C0-8FEF-8C1B93B1DE9E

P478

Q37689787-AFE18B6F-671E-463C-BECF-676EA6E58993

P577

Q37689787-BE6CE228-A92A-4276-BE06-092148F75C74

P698

Q37689787-7D5AF13A-3AF7-4EA6-B3D4-AC519FFE5B4F

P921

Q37689787-cfa50602-1f1c-4b5a-ba02-2d5ca1ed73f0

P356

13543776.17.8.889

P1433

Expert Opinion on Therapeutic Patents

P1476

Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.

@en

P2093

Wendol A Williams

http://www.w3.org/2001/XMLSchema#string

Yiyun Huang

http://www.w3.org/2001/XMLSchema#string

P2860

SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

Alterations in 5-HT1B receptor function by p11 in depression-like states

SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Syntheses and Binding Studies of New [(Aryl)(aryloxy)methyl]piperidine Derivatives and Related Compounds as Potential Antidepressant Drugs with High Affinity for Serotonin (5-HT) and Norepinephrine (NE) Transporters

Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans.

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.

Serotonin autoreceptor function and antidepressant drug action.

P304

889-907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.17.8.889

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20144065

http://www.w3.org/2001/XMLSchema#string

P921